TL;DR
- •Trazodone has two very different use patterns: low-dose (25-100mg) for sleep, and high-dose (300-600mg) for depression. The taper experience differs significantly between these patterns.
- •Low-dose-for-sleep trazodone discontinuation is usually mild — most patients can taper or even stop abruptly without severe withdrawal, though rebound insomnia is common (similar to Ambien rebound but typically less intense).
- •High-dose-for-depression trazodone tapers can produce SSRI-like discontinuation symptoms (dizziness, nausea, anxiety, sleep disruption) because of the serotonergic effects at higher doses.
- •Trazodone's half-life is short (~7 hours), which structurally suggests it should have a harder discontinuation profile — but the doses commonly used for sleep are low enough that withdrawal is muted.
- •For patients using trazodone for sleep secondary to depression, ketamine response often resolves the underlying depression and reduces the need for sleep medication. The trazodone taper then becomes straightforward.
- •For patients on high-dose trazodone for depression specifically, the mechanism switch to ketamine works the same way as switching from any other antidepressant — different pathway, no withdrawal syndrome.
Why people decide to taper
- •Original insomnia resolved (often after depression treatment)
- •Next-day grogginess or sedation
- •Cardiovascular concerns (priapism risk in men, QT-interval considerations)
- •Sexual dysfunction (less common than SSRIs but possible)
- •Switching to a different sleep approach or antidepressant
- •Comfort with non-pharmacologic sleep strategies (CBT-I)
What withdrawal looks like
Trazodone discontinuation varies dramatically by dose. Low-dose-for-sleep (25-100mg): often minimal withdrawal, primarily rebound insomnia and sometimes mild anxiety for a few nights. High-dose-for-depression (200-600mg): can produce more pronounced SSRI-like symptoms including dizziness, nausea, anxiety, irritability, headache, sleep disruption, and occasionally brain-zap-like sensations. The high-dose pattern is closer to typical antidepressant withdrawal because the serotonergic effects become more pronounced at antidepressant doses.
Typical taper timeline
Low-dose-for-sleep trazodone: 1-4 weeks of taper usually sufficient. High-dose-for-depression trazodone: 4-8 weeks for short-term users, several months for long-term users — similar to SSRI tapering schedules. The dose matters more than duration for predicting taper difficulty.
Taper approaches
Options to bring to your prescriber. The dose-by-dose plan belongs to your prescriber, not this page.
Linear taper for low-dose sleep use
For patients on 25-100mg for sleep, reducing by 25-50mg every 1-2 weeks usually produces only mild rebound insomnia. The 50mg/100mg/150mg/300mg tablet strengths allow reasonable steps.
Hyperbolic taper for high-dose depression use
For patients on 200mg+ for depression, hyperbolic tapering (proportional reductions) produces less withdrawal than linear schedules. Standard "reduce 100mg every 2 weeks" approaches at high doses can produce significant withdrawal.
Start CBT-I if trazodone is for sleep
Cognitive-behavioral therapy for insomnia is the evidence-based first-line treatment for chronic insomnia. Starting CBT-I before tapering trazodone gives patients alternative sleep strategies to handle rebound insomnia.
Address depression with different treatment
For patients on high-dose trazodone for depression, the taper requires a parallel depression-treatment plan — either switching to a different antidepressant, adding therapy, or transitioning to a different mechanism like ketamine.
Compounded liquid trazodone for sensitive patients
For very-small dose reductions below the 50mg tablet floor, compounded liquid trazodone allows fine titration. Rarely needed but useful for sensitive patients at the end of taper.
Mechanism switch to ketamine
For high-dose-for-depression trazodone patients, ketamine offers a different antidepressant mechanism with episodic dosing. The trazodone taper happens in parallel with the ketamine treatment establishing mood support.
What’s specific to Trazodone
Trazodone is an atypical antidepressant — serotonin receptor antagonism (5-HT2A) plus weak serotonin reuptake inhibition, with prominent histamine-1 (H1) antagonism. The H1 antagonism produces the sedation that makes low-dose trazodone widely prescribed off-label for sleep. At low doses (25-100mg) used for sleep, the serotonergic effect is minimal and the H1 sedation dominates — which is why low-dose taper produces mainly rebound insomnia rather than SSRI-style withdrawal. At high doses (300-600mg) used for depression, the serotonergic effect becomes significant and the discontinuation profile shifts toward typical SSRI-style withdrawal. Half-life is short (~7 hours) — relatively unusual among antidepressants and the reason higher-dose tapers can produce withdrawal despite the medication's "kinder" reputation. Available formulations: 50mg/100mg/150mg/300mg tablets. The 100mg+ tablets are scored and can be cut. Trazodone has notable cardiovascular caveats: priapism risk in men (rare but serious), QT-interval prolongation at higher doses. Discontinuation should not produce cardiovascular complications, but baseline cardiac status matters during prescribing.
Where ketamine fits
For patients using trazodone for sleep secondary to depression, the relationship is often: depression caused insomnia → insomnia drove trazodone prescription → depression improved with other treatment → insomnia persisted → trazodone continued. Ketamine's antidepressant effect can resolve underlying depression that was contributing to the insomnia, after which the trazodone taper becomes straightforward. For patients on high-dose trazodone for depression specifically, the mechanism switch to ketamine works like switching from any other antidepressant — different pathway (NMDA/glutamate vs serotonin signaling), no withdrawal syndrome, episodic dosing rather than daily. Many Tovani patients on trazodone find that ketamine response allows them to discontinue trazodone without the sleep problem returning, because the depression that was driving both is now treated.
Check eligibility for ketamine therapy5-minute screening · Reviewed by a board-certified physician · FL & NJ
Frequently asked
Will I have withdrawal coming off trazodone for sleep?
Usually mild for low-dose (25-100mg) sleep use. The main symptom is rebound insomnia for a few nights after stopping — sleep can be worse than it was before trazodone was started, but typically resolves within 1-2 weeks. Some patients experience brief anxiety or mood changes during this period. Severe withdrawal is uncommon at low-dose sleep ranges.
Is trazodone withdrawal worse at higher doses?
Yes — meaningfully so. At depression-treating doses (200-600mg), trazodone produces more pronounced serotonergic effects, and discontinuation can produce SSRI-style withdrawal symptoms (dizziness, nausea, anxiety, brain-zap sensations). Patients on high-dose trazodone for depression should plan a slower taper than low-dose-for-sleep patients.
Should I taper trazodone or just stop?
For short-term users (a few weeks) on low doses (25-50mg), abrupt discontinuation is usually fine — main symptom is a few nights of rebound insomnia. For long-term users or higher doses (100mg+), a structured taper produces a smoother experience. Discuss with your prescriber.
What about rebound insomnia after stopping?
Common for any sleep-related medication taper, including trazodone. Typically peaks in the first week and resolves within 1-2 weeks. CBT-I started before the taper provides alternative sleep strategies and substantially reduces rebound intensity. For chronic insomnia, CBT-I is the evidence-based first-line treatment regardless of which sleep medication is being discontinued.
I take trazodone for depression-related insomnia. Will ketamine help?
Often yes — through an indirect mechanism. Ketamine doesn't directly treat insomnia, but resolving underlying depression often resolves the insomnia that drove trazodone prescription in the first place. Many Tovani patients find that ketamine response creates conditions where trazodone is no longer needed, making the taper straightforward.
Never taper without prescriber coordination
Withdrawal symptoms can mimic depression or anxiety relapse, and untreated relapse can be more dangerous than withdrawal. Stopping benzodiazepines abruptly can produce seizures. Bring this page to your prescriber as a conversation starter — they translate options into your specific plan.
References
- Cuomo A et al. 2026, Annals of General Psychiatry. Narrative review of trazodone as multimodal antidepressant — covers pharmacokinetics, dosing-dependent effects, and clinical relevance of formulation and dosing during use and discontinuation. PMID 41845402
- Young AH et al. 2026, European Psychiatry. European Delphi expert consensus on trazodone in major depressive disorder — addresses appropriate use and considerations for discontinuation across the dose range. PMID 41645529
- Henssler J et al. 2024, Lancet Psychiatry. Meta-analysis of antidepressant discontinuation symptoms — relevant framework for trazodone discontinuation at antidepressant doses despite the medication's "kinder" reputation. PMID 38851198